IVAD recall designated Class I
This article was originally published in The Silver Sheet
Thoratec has initiated a worldwide recall of implantable ventricular assist devices (IVADs) due to problems with the product's driveline. Seven reports of damaged drivelines in the IVADs - which resulted in five patient injuries and one death - have been received by the firm, leading it to submit a Class II recall notification to FDA Oct. 19, later upgraded by FDA to Class I. The affected models were manufactured and distributed after October 2004. The current instructions for use say the IVADs can be placed internally, or in the paracorporeal (external) position. When outside the body, the device's driveline can be damaged if it is bent at a sharp angle, potentially reducing or interrupting circulatory support to the patient, the firm says
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.